4.09 USD
↘ 0.24 (5.54%)AT CLOSE (11:59 AM EDT)
Cytek Biosciences, Inc. Common Stock (CTKB) is currently trading at $4.09. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". This is driven by a robust Altman Z-Score, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest CTKB is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Jun 5, 2026.